{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T12:22:37Z","timestamp":1773145357917,"version":"3.50.1"},"reference-count":30,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2006,3,9]],"date-time":"2006-03-09T00:00:00Z","timestamp":1141862400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["bjui-journals.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["BJU International"],"published-print":{"date-parts":[[2006,4]]},"abstract":"<jats:sec>\n                    <jats:title>OBJECTIVE<\/jats:title>\n                    <jats:p>\n                      To investigate, in a human urinary tract cell line, the interaction of Toll\u2010like receptor (TLR) signals with cytoplasmic adapter proteins MyD88 and bacillus Calmette\u2010Gu\u00e9rin (BCG), and evaluate the epithelial cytokine response to BCG infection. Intravesical BCG therapy is effective against carcinoma\n                      <jats:italic>in situ<\/jats:italic>\n                      and as prophylaxis for recurrence, but although immunological mechanisms have been assumed, the mechanisms of the antitumour effects of BCG have not been completely elucidated.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>MATERIALS AND METHODS<\/jats:title>\n                    <jats:p>The cell line was first screened for TLR expression by reverse transcription\u2010polymerase chain reaction (RT\u2010PCR). Total RNA was isolated from a human urinary cell line, Hu35E6E7, and cDNA synthesised. PCR was used to measure the gene expression of TLR\u20102, \u20103, \u20104, \u20105, \u20109, MyD88, MD\u20102, CD14 and interleukin\u20108 and \u20106. The Hu35E6E7 cell line was cultured in keratinocyte serum\u2010free medium, and BCG was added to the cell culture. After Hu35E6E7 cells were stimulated by BCG for various periods, the total RNA of the cells was extracted. Quantitative real\u2010time PCR was conducted for MyD88 using appropriate probes, and the expression of MyD88 analysed. The cell supernatant was collected, and the levels of interferon\u2010\u03b3, tumour necrosis factor\u2010\u03b1, interleukin\u20102, \u201012, \u20104, \u20106, \u201010, \u20108 and \u20101\u03b2 were assayed using an enzyme\u2010linked immunosorbent assay.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS<\/jats:title>\n                    <jats:p>Uroepithelial cells expressed TLR\u20102, \u20103, \u20104 and \u20109, and MyD88, MD2, CD14, interleukin\u20106 and \u20108 were also detected. At 3, 6, 9 and 12\u2003h after adding BCG, quantitative PCR assay showed that the expression of MyD88 was maximal at 6\u2003h. The presence of BCG stimulated the release only of interleukin\u20106 and \u20108 from Hu35E6E7 cells after 6\u2003h. By contrast, interferon\u2010\u03b3, tumour necrosis factor\u2010\u03b1, interleukin\u20102, \u201012, \u20104, \u201010 and \u20101\u03b2 were not detected in the culture supernatant.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSION<\/jats:title>\n                    <jats:p>These results show that uroepithelial cells, but not immune cells, responded directly to BCG through TLR signalling. Further investigation is needed to determine the role of cytokines released from uroepithelial cells after BCG infection.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1111\/j.1464-410x.2006.06026.x","type":"journal-article","created":{"date-parts":[[2006,3,9]],"date-time":"2006-03-09T08:52:21Z","timestamp":1141894341000},"page":"860-864","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Uroepithelial cells can directly respond to\n                    <i>Mycobacterium bovis<\/i>\n                    bacillus Calmette\u2010Gu\u00e9rin through Toll\u2010like receptor signalling"],"prefix":"10.1111","volume":"97","author":[{"given":"JUN","family":"MIYAZAKI","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"KOJI","family":"KAWAI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"TAKEHIRO","family":"OIKAWA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"AKIRA","family":"JOHRAKU","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"KAZUNORI","family":"HATTORI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"TORU","family":"SHIMAZUI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"HIDEYUKI","family":"AKAZA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2006,3,9]]},"reference":[{"key":"e_1_2_7_2_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19950115)75:2<552::AID-CNCR2820750219>3.0.CO;2-H"},{"key":"e_1_2_7_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(17)40002-4"},{"key":"e_1_2_7_4_2","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S0094-0143(21)00423-7","article-title":"Complications of bacillus Calmette\u2010Guerin immunotherapy","volume":"19","author":"Lamm DL","year":"1992","journal-title":"Urol Clin North Am"},{"issue":"1","key":"e_1_2_7_5_2","first-page":"253","article-title":"New strategy of bio\u2010chemoprevention on recurrence of superficial bladder cancer based on a hypothesis of the mechanism of recurrence","volume":"24","author":"Akaza H","year":"1997","journal-title":"Gan To Kagaku Ryoho"},{"key":"e_1_2_7_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(01)66424-3"},{"key":"e_1_2_7_7_2","doi-asserted-by":"publisher","DOI":"10.1159\/000474916"},{"key":"e_1_2_7_8_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.68.12.6883-6890.2000"},{"key":"e_1_2_7_9_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00296835"},{"key":"e_1_2_7_10_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.ju.0000067623.43110.4c"},{"key":"e_1_2_7_11_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1442-2042.2002.00415.x"},{"key":"e_1_2_7_12_2","first-page":"661","article-title":"Balance between activated\u2010STAT and MAP kinase regulates the growth of human bladder cell lines after treatment with epidermal growth factor","volume":"15","author":"Kawamata H","year":"1999","journal-title":"Int J Oncol"},{"key":"e_1_2_7_13_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.71.2.717-725.2003"},{"key":"e_1_2_7_14_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.70.7.3433-3442.2002"},{"key":"e_1_2_7_15_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1462-5822.2001.00101.x"},{"key":"e_1_2_7_16_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.167.7.3555"},{"key":"e_1_2_7_17_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1349-7006.1988.tb00049.x"},{"key":"e_1_2_7_18_2","doi-asserted-by":"publisher","DOI":"10.1038\/35047123"},{"key":"e_1_2_7_19_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M002896200"},{"key":"e_1_2_7_20_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.72.6.3179-3186.2004"},{"key":"e_1_2_7_21_2","doi-asserted-by":"publisher","DOI":"10.1038\/90609"},{"key":"e_1_2_7_22_2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.immunol.21.120601.141126"},{"key":"e_1_2_7_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1369-5274(99)80017-4"},{"key":"e_1_2_7_24_2","doi-asserted-by":"publisher","DOI":"10.1086\/317603"},{"key":"e_1_2_7_25_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0736473100"},{"key":"e_1_2_7_26_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2249.2003.02071.x"},{"key":"e_1_2_7_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0161-5890(02)00210-9"},{"key":"e_1_2_7_28_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00941903"},{"key":"e_1_2_7_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0090-4295(01)00921-9"},{"key":"e_1_2_7_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1471-4892(03)00080-8"},{"key":"e_1_2_7_31_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.170.7.3451"}],"container-title":["BJU International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1464-410X.2006.06026.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/bjui-journals.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1464-410X.2006.06026.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T11:52:56Z","timestamp":1761738776000},"score":1,"resource":{"primary":{"URL":"https:\/\/bjui-journals.onlinelibrary.wiley.com\/doi\/10.1111\/j.1464-410X.2006.06026.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,3,9]]},"references-count":30,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2006,4]]}},"alternative-id":["10.1111\/j.1464-410X.2006.06026.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1464-410x.2006.06026.x","archive":["Portico"],"relation":{},"ISSN":["1464-4096","1464-410X"],"issn-type":[{"value":"1464-4096","type":"print"},{"value":"1464-410X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,3,9]]},"assertion":[{"value":"2006-03-09","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}